6 medicines held by Takeda Products Ireland Ltd on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/001 |
Leuprorelin acetate | Takeda Products Ireland Ltd | Marketed |
| PROSTAP 6 DCS 30 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/002 |
Leuprorelin acetate | Takeda Products Ireland Ltd | Marketed |
| PROSTAP SR DCS 3.75 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/003 |
Leuprorelin acetate | Takeda Products Ireland Ltd | Marketed |
| Protium 20 mg gastro-resistant tablets PA2229/010/001 |
Pantoprazole sodium sesquihydrate | Takeda Products Ireland Ltd | Marketed |
| Protium 40 mg gastro-resistant tablets PA2229/010/002 |
Pantoprazole | Takeda Products Ireland Ltd | Marketed |
| Protium i.v. 40 mg Powder for Solution for Injection PA2229/010/003 |
Pantoprazole | Takeda Products Ireland Ltd | Marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.